VEMLIDY

Product Overview

About VEMLIDY

VEMLIDY is a prescription medication containing the active ingredient Tenofovir alafenamide (Tenofovir alafenamide hemifumarate), used to treat chronic hepatitis B (HBV) infection in adults with compensated liver disease.

Key Benefits & Uses

• Treatment of chronic hepatitis B (HBV) infection in adults with compensated liver disease.
• Reduction of liver inflammation and fibrosis associated with HBV infection.
• Prevention of liver disease progression and complications in HBV-infected patients.

Active Ingredient & Action

Tenofovir alafenamide (Tenofovir alafenamide hemifumarate) is a nucleotide reverse transcriptase inhibitor (NtRTI) that works by inhibiting the replication of the hepatitis B virus (HBV) in the liver. It is a prodrug that is converted to its active form, tenofovir, which then inhibits the HBV DNA polymerase, preventing the virus from replicating and reducing liver inflammation and fibrosis.

Important Notes

VEMLIDY is available only by prescription and should be used under the guidance of a healthcare professional. It is essential to follow the recommended dosage and treatment regimen to achieve optimal results and minimize the risk of side effects. Regular monitoring of liver function and HBV viral load is recommended during treatment with VEMLIDY.